Literature DB >> 34740036

Amelioration of enteric dysbiosis by polyoxotungstates in mice gut.

Kun Chen1, Yuan Liu2, Mu Li3, Lu Liu4, Qiang Yu3, Long Wu5.   

Abstract

Here we show that Preyssler-type polyoxotungstates (Preyssler-type POTs, [NaP5W30O110]-14) complexed with peptides can prevent the dysbiotic expansion of anaerobic bacteria of the Enterobacteriaceae family. In a dextran sulfate sodium (DSS)-induced colitis model, symptom remission of C57BL/6 J mice with colitis is achieved by orally treated with POT complexes. Ten days of daily administration of POT complexes reduces 5% body weight loss and the mRNA levels of proinflammatory markers (77% reduction for Il6, 73% reduction for Tnf, 91% reduction for Cxcl1) in the caecum and proximal colon. Bacterial population analysis reveals that these Enterobacteriaceae population in the caecal content decline by one order of magnitude after administration of POT complexes. POT complexes exert anti-inflammatory effects indirectly on the host immune system by inhibition of malignant expansion of anaerobic Enterobacteriaceae during gut inflammation. Furthermore, POTs show negligible effect on bacterial growth in vitro, healthy mice and their microbiota composition under homeostatic conditions. Rationally designed POT complexes will provide distinctive approach to improve enteric bacteria dysbiosis-associated gut inflammation by balancing bacterial communities.
Copyright © 2021 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Anti-inflammation; Enteric bacteria; Intestinal dysbiosis; Metal oxide clusters; Polyoxotungstates

Mesh:

Substances:

Year:  2021        PMID: 34740036     DOI: 10.1016/j.jinorgbio.2021.111654

Source DB:  PubMed          Journal:  J Inorg Biochem        ISSN: 0162-0134            Impact factor:   4.155


  1 in total

1.  Degradation and Detection of Endocrine Disruptors by Laccase-Mimetic Polyoxometalates.

Authors:  Kun Chen; Shengqiu Liu; Qiongyu Zhang
Journal:  Front Chem       Date:  2022-02-16       Impact factor: 5.221

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.